Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Johnson & Johnson (

Stock Index Futures are Higher after Wholesale Prices Increased Less Than Expected in March

June S&P 500 E-Mini futures (ESM24) are up 0.02%, and June Nasdaq 100 E-Mini futures (NQM24) are up 0.17%% this morning, after the release of the PPI data.

Barchart

Stock Index Futures Slip as Rate Cut Hopes Fade, U.S. PPI Data and ECB Decision in Focus

June S&P 500 E-Mini futures (ESM24) are down -0.36%, and June Nasdaq 100 E-Mini futures (NQM24) are down -0.30% this morning, signaling further losses on Wall Street after hotter-than-expected U.S. inflation data diminished hopes of early interest rate cuts by the Federal Reserve, while investors awaited crucial U.S. producer inflation…

Barchart

Johnson & Johnson Acquires Shockwave Medical For Billion

Johnson & Johnson invests billion to acquire Shockwave Medical, a leader in heart care technology.

Top News

4 Pharma Titans Making Waves in Wall Street

The pharma industry is well-positioned to remain buoyed, owing to the rise in chronic diseases, a growing elderly population, and the integration of advanced technologies. Given this backdrop, quality pharma stocks Bristol-Myers Squibb Company (BMY), Johnson & Johnson (JNJ), Novartis AG (NVS), and Merck & Co. (MRK), making waves in…

StockNews.com

3 Pharma Stocks With Prescription for Stability and Value in March

Amid rising healthcare demand globally, advancements in precision medicine, and the booming e-pharmacy market, the pharmaceutical industry is expected to witness significant long-term growth. Hence, fundamentally sound pharma stocks Dr. Reddy’s Laboratories (RDY), Ipsen (IPSEY), and Johnson & Johnson (JNJ), which boast low beta values and attractive valuation metrics, might…

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

4 Top Dividend Kings to Earn Passive Income

Dividend Kings are companies with a long history of paying and increasing shareholder dividends, which signals strong financial health for investors looking to build a steady stream of passive income.

Barchart

20 Highest-Grossing Biotech Stocks: Giants Driving Innovation and Growth

Biotech stocks offers the potential for significant returns driven by breakthrough discoveries and advancements in healthcare, agriculture, and other industries.

International Business Times

Pfizer (PFE) vs. Johnson & Johnson (JNJ) - Analyzing Pharma Stocks for Upside Potential

The pharmaceutical industry is expected to witness robust growth over the coming years due to growing healthcare needs and advancements in technology. Given this positive backdrop, let’s analyze the upside potential of pharma stocks Pfizer (PFE) and Johnson & Johnson (JNJ).

StockNews.com

Senators ask CEOs why their drugs cost so much more in the U.S.

The Senate HELP committee questioned pharmaceutical CEOs about how much more Americans pay for the same drugs sold for less in Canada, Japan and Europe.

WEKU

Merck, Johnson & Johnson CEOs agree to appear before Senate HELP - Roll Call

Two drug company CEOs have agreed to testify before the Senate HELP Committee on drug prices, avoiding a scheduled subpoena vote on Jan. 31.

Roll Call

Johnson & Johnson (JNJ): Analyzing Signals Before Quarterly Earnings

Pharmaceutical powerhouse Johnson & Johnson (JNJ) is proactively driving innovation throughout the healthcare spectrum, thanks to its strong focus on innovative medicines and MedTech solutions. However, with the company’s fiscal fourth-quarter earnings on the horizon, could the stock be a wise portfolio addition? Keep reading to find out….

StockNews.com

Families condemn Koch brothers over ploy to avoid asbestos compensation

Georgia-Pacific, owned by Koch Industries, employ controversial legal tactic to circumvent paying millions to sickened workers

The Guardian - US

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

2 Dividend Kings Yielding Around 3% to Grab Now

High yields aren't the only reason to buy shares of dividend-paying stocks. For investors seeking quality dividend stocks for passive income, here's a look at two companies with long track records of raising shareholder payouts.

iMore

Apple's board of directors welcomes space program expert — Dr. Wanda Austin joins as Al Gore departs

Dr. Wanda Austin has joined Apple's board of directors, while former U.S. VP Al Gore has departed.

Barchart

Strength in Tech Stocks Powers the Overall Market Higher

What you need to know… The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +1.41%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.58%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +2.11%. Stocks on Monday settled moderately higher, with the...

Barchart

Stocks Mostly Higher on Strength in Tech and a Decline in Bond Yields

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is up +0.51%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.17%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.20%. Stocks this morning are mixed, with the Dow Jones...

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Markets Today: Stocks Climb on M&A Activity and Lower Bond Yields

Morning Markets March E-Mini S&P 500 futures (ES H24) are up +0.06%, and March Nasdaq 100 E-Mini futures (NQH2 4) are up +0.18%. Stock index futures this morning are moderately higher. An increase in M&A activity supports stocks after Boston Scientific agreed to buy Axionics for $3.7 billion and Johnson...

The Guardian - US

Will Matthew Perry’s death spell the end of the ketamine wellness industry?

The actor’s autopsy revealed he had died from taking ketamine, currently being touted as a miracle treatment for mental health problems

WEKU

In 2023, opioid settlement funds flowed to states. Here's how it's going

Some $1.5 billion flowed to local government coffers this year, sparking debates about transparency and how to spend the money. Here are 5 takeaways from a year's worth of reporting on the issue.

StockNews.com

3 Solid Pharma Stocks for a Healthy Year-End Portfolio

The pharma industry is transforming due to the rapid adoption of AI and global healthcare spending, fostering innovation and patient care advancements. Therefore, fundamentally sound pharma stocks Eli Lilly (LLY), Wave Life Sciences (WVE) and Johnson & Johnson (JNJ) might be worth adding to boost your portfolio. Continue reading.

Fortune

A CEO contender left Johnson & Johnson. Was she penalized for saying she wanted the job?

The exit of a Johnson & Johnson exec raises an age-old question about women's ambition.

Fortune

His dad worked on the factory floor at Johnson & Johnson. Now he’s the CFO

Joe Wolk, with J&J for over 25 years, talks about his path and the company's focus on innovation.

Fortune

Breakthrough antidepressants with fewer side effects could help millions of Americans. Here's what the future of treatment may look like

As Americans are increasingly reaching for pharmaceutical solutions for depression—about one in eight U.S. adults takes antidepressants—scientists have been innovating novel treatments for it.

1 … 9 10 11 12

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.